/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE
SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES./
LONDON, ON, Sept. 26, 2018 /CNW/ - INDIVA Limited (the
"Company" or "INDIVA") (TSXV: NDVA) is pleased to
announce that it has been included in the Horizons Marijuana Life
Sciences exchange-traded fund (TSX: HMMJ). The HMMJ is a fund
that provides investors with a basket of North American publicly
listed businesses active in the marijuana industry.
"Investors that prefer a more diversified portfolio and would
like to own INDIVA will now be able to do so through HMMJ. We
see this development further improving the liquidity of our shares
which is a positive development for all INDIVA shareholders,"
announced Niel Marotta, CEO.
About INDIVA
INDIVA's wholly owned subsidiary
is a Licensed Producer under Canada's Access to Cannabis for Medical
Purposes Regulation ("ACMPR").
INDIVA's mission is to offer cannabis products that have a
positive impact, improving lives and
communities.
DISCLAIMER & READER ADVISORY
Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) has in
any way passed upon the merits of the Transaction and neither of
the foregoing entities accepts responsibility for the adequacy or
accuracy of this release or has in any way approved or disapproved
of the contents of this press release.
Certain statements contained in this press release constitute
forward-looking information. These statements relate to future
events or future performance. The use of any of the words "could",
"intend", "expect", "believe", "will", "projected", "estimated" and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking
information and are based on the parties' current belief or
assumptions as to the outcome and timing of such future events.
Actual future results may differ materially. In particular, this
release contains forward-looking information relating to the
Company's inclusion in HMMJ. Various assumptions or factors are
typically applied in drawing conclusions or making the forecasts or
projections set out in forward-looking information. Those
assumptions and factors are based on information currently
available to Indiva. The material factors and assumptions include
Indiva being able to obtain necessary corporate, regulatory and
other third-party approvals. The forward looking information
contained in this release is made as of the date hereof and the
parties are not obligated to update or revise any forward looking
information, whether as a result of new information, future events
or otherwise, except as required by applicable securities laws.
Because of the risks, uncertainties and assumptions contained
herein, investors should not place undue reliance on forward
looking information. The foregoing statements expressly qualify any
forward-looking information contained herein.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities in
the United States. The securities
have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "U.S. Securities Act") or
any state securities laws and may not be offered or sold within
the United States or to U.S.
Persons unless registered under the U.S. Securities Act and
applicable state securities laws or an exemption from such
registration is available. Not for distribution to U.S. Newswire
Services or for dissemination in the
United States. Any failure to comply with this restriction
may constitute a violation of U.S. Securities laws.
SOURCE Indiva Limited